Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System

NCT01028937 is registered in ClinicalTrials.gov with NTK Enterprises, Inc. as lead sponsor.

NCT NCT01028937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01028937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hyperopia Correction Using the NTK Optimal Keratoplasty (Opti-K) System
Lead sponsor
NTK Enterprises, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2009
Completion date
January 31, 2018
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperopia